5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow Hypogonadotropic Hypogonadism: new trials by email Literature Review of Hypogonadotropic Hypogonadism trials Research Report on Hypogonadotropic Hypogonadism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism kisspeptin 112-121, GnRH - Hypogonadotropic Hypogonadism | Phase 2 | Completed | Stephanie B. Seminara, MD | 18 | 2019-05-03 | 2026-08-26 |
| A 6 Month Safety Extension Study of MBGS205 BGS649 - Hypogonadotropic Hypogonadism | Phase 2 | Completed | Mereo BioPharma | 143 | 2016-11-15 | 2023-05-18 |
| Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism BGS649, Placebo - Hypogonadotropic Hypogonadism | Phase 2 | Completed | Mereo BioPharma | 271 | 2016-05-12 | 2022-09-14 |
| Effect of Intranasal Insulin on LH Concentrations in Man intranasal insulin, placebo (intranasal saline) - Hypogonadotropic Hypogonadism | Phase 1 / Phase 2 | Completed | Texas Tech University Health Sciences Center | 14 | 2014-12-01 | 2019-08-13 |
| Clomiphene in Males With Prolactinomas and Persistent Hypogonadism Clomiphene citrate - Hypogonadotropic Hypogonadism, Prolactinoma | Phase 2 | Completed | Federal University of São Paulo | 15 | 2004-06-01 | 2008-06-16 |
Hypogonadism (5) · Prolactinoma (1)
Endocrine System Diseases (5) · Gonadal Disorders (5) · Adenoma (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Endocrine Gland Neoplasms (1) · Hypothalamic Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Nervous System Diseases (1) · Pituitary Diseases (1) · Pituitary Neoplasms (1)
Clomiphene (1) · Gonadotropin-Releasing Hormone (1) · leflutrozole (1)
Mereo BioPharma (2) · Federal University of São Paulo (1) · Stephanie B. Seminara, MD (1) · Texas Tech University Health Sciences Center (1)
United States (4) · Brazil (1) · Italy (1) · Spain (1) · United Kingdom (1)
Hugh Jones (2) · Julio Abucham, MD, PhD (1) · Sandeep Dhindsa, MD (1) · Stephanie Seminara (1)